Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:CTX)

Fundamentals Snapshot (TSX:CTX)

Opinion & Analysis (TSX:CTX)

No current opinion is available.

Bullboard Posts (TSX:CTX)

RE:RE:Ghost town here

Tell that to the share price... EV at $0.80 is roughly $5.3M.. lumpy or not the TTM EBITDA is $1M (anticipated to grow with the...
Stonksonlyup90 - March 24, 2022

RE:Ghost town here

Co. has lumpy revenues due to 1-time upfront licensing fees so looking at a qtr is unwise. 12 month revenues little changed and...
lscfa - March 24, 2022

RE:Ghost town here

Let's hope this get higher. It's really undervalued
Eldoradosucks - March 23, 2022

Ghost town here

Company just posted phenomenal Q4 results and not a peep here or on other investor boards that I follow... this name is soooo undervalued...
Stonksonlyup90 - March 23, 2022

RE:RE:RE:RE:Trading below cash value

recently announced another bid to where the company "intends" to purchase 1M shares over the next year. Great idea, they have...
matt2018 - December 24, 2021

RE:RE:RE:Trading below cash value

signature product Pliaglis in 40 countries now. good time for larger player to come along and scoop this up using the companys cash on...
matt2018 - December 23, 2021